ACP5 and rheumatoid arthritis: However, the response to TGFβ1 differs between these two populations; the number of TRAP-positive MNCs generated from PBMs treated with M-CSF, RANKL, and TGFβ1 in healthy controls was significantly lower than those in patients with RA.